12 Dec, 11:49 - Indian

SENSEX 81432.78 (-0.11)

Nifty 50 24600.1 (-0.17)

Nifty Bank 53367.95 (-0.04)

Nifty IT 45819.35 (1.03)

Nifty Midcap 100 59121 (-0.29)

Nifty Next 50 73239.2 (-0.07)

Nifty Pharma 22232.3 (-0.32)

Nifty Smallcap 100 19524.25 (-0.68)

12 Dec, 11:49 - Global

NIKKEI 225 39849.14 (1.21)

HANG SENG 20485.44 (1.64)

S&P 6098 (-0.11)

Login/Signup

You are Here : Home > Research

31-Jan-2024

Dr Reddys Laboratories

NP up 11.01%

'For the quarter ending Dec 2023, consolidated Net sales (including other operating income) of Dr Reddys Laboratories has increased 6.58% to Rs 7236.8 crore compared to quarter ended Dec 2022.  Sales of Pharmaceutical Services segment has gone up 2.68% to Rs 1,058.00 crore (accounting for 14.12% of total sales).  Sales of Global Generics segment has gone up 6.49% to Rs 6,312.40 crore (accounting for 84.26% of total sales).  Sales of Others segment has gone up 73.08% to Rs 121.50 crore (accounting for 1.62% of total sales).  Inter-segment sales rose Rs 238.40 crore to Rs 255.10 crore.  

Profit before interest, tax and other unallocable items (PBIT) has jumped 5.26% to Rs 4,220.70 crore.  PBIT of Pharmaceutical Services segment rose 63.27% to Rs 230.70 crore (accounting for 5.47% of total PBIT).  PBIT of Global Generics segment rose 2.15% to Rs 3,907.70 crore (accounting for 92.58% of total PBIT). &...



Pleaselogin & subscribe to view the full report.

More Reports
More Reports View Company Information